Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.24 HKD | +5.47% | +7.34% | -19.39% |
Mar. 21 | Sisram Medical’s Profit Down in Fiscal 2023 | MT |
Mar. 20 | Sisram Medical Ltd Announces Ordinary Final Cash Dividend for the Year Ended December 31, 2023 | CI |
Sales 2024 * | 394M 3.08B | Sales 2025 * | 438M 3.42B | Capitalization | 254M 1.99B |
---|---|---|---|---|---|
Net income 2024 * | 35M 273M | Net income 2025 * | 40M 313M | EV / Sales 2024 * | 0.64 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.58 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,071 |
Yield 2024 * |
3.69% | Yield 2025 * |
5.53% | Free-Float | 28.43% |
1 day | +5.47% | ||
1 week | +7.34% | ||
Current month | +15.22% | ||
1 month | +19.77% | ||
3 months | +6.53% | ||
6 months | -26.26% | ||
Current year | -19.39% |
Managers | Title | Age | Since |
---|---|---|---|
Lior Moshe Dayan
CEO | Chief Executive Officer | 54 | 17-06-05 |
Nikol Lev
CTO | Chief Tech/Sci/R&D Officer | - | - |
Itay Meir
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Heung Sang Fong
BRD | Director/Board Member | 64 | 16-12-31 |
Yi Fang Wu
BRD | Director/Board Member | 54 | 16-10-16 |
Lior Moshe Dayan
CEO | Chief Executive Officer | 54 | 17-06-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +4.81% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 4.24 | +5.47% | 1,047,600 |
24-05-09 | 4.02 | +7.77% | 1,094,400 |
24-05-08 | 3.73 | -5.09% | 614,000 |
24-05-07 | 3.93 | -0.76% | 513,200 |
24-05-06 | 3.96 | 0.00% | 543,035 |
Delayed Quote Hong Kong S.E., May 10, 2024 at 04:08 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.39% | 254M | |
+18.15% | 993M | |
-29.14% | 82.52M |
- Stock Market
- Equities
- 1696 Stock